Starjemza Purple Book BLA 761419

BLA number
761419
Proprietary names
Starjemza
Proper names
ustekinumab-hmny
Applicant
Bio-Thera Solutions, Ltd.
Center
CDER
First observed release
2025-05-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Starjemzaustekinumab-hmny351(k) Interchangeable45MG/0.5MLInjectionSubcutaneousPre-Filled SyringeRxLicensed2025-05-22
002Starjemzaustekinumab-hmny351(k) Interchangeable90MG/MLInjectionSubcutaneousPre-Filled SyringeRxLicensed2025-05-22
003Starjemzaustekinumab-hmny351(k) Interchangeable45MG/0.5MLInjectionSubcutaneousSingle-Dose VialRxLicensed2025-05-22
004Starjemzaustekinumab-hmny351(k) Interchangeable130MG/26ML (5MG/ML)InjectionIntravenousSingle-Dose VialRxLicensed2025-05-22

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2025-05-01N001Starjemza351(k) InterchangeableRxBio-Thera Solutions, Ltd.
2025-05-01N002Starjemza351(k) InterchangeableRxBio-Thera Solutions, Ltd.
2025-05-01N003Starjemza351(k) InterchangeableRxBio-Thera Solutions, Ltd.
2025-05-01N004Starjemza351(k) InterchangeableRxBio-Thera Solutions, Ltd.

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2025-05-01001Starjemza351(k) InterchangeableRxLicensed2025-05-22
2025-05-01002Starjemza351(k) InterchangeableRxLicensed2025-05-22
2025-05-01003Starjemza351(k) InterchangeableRxLicensed2025-05-22
2025-05-01004Starjemza351(k) InterchangeableRxLicensed2025-05-22